Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism.

An essential element of the innate immune response to injury is the capacity to recognize microbial invasion and stimulate production of antimicrobial peptides. We investigated how this process is controlled in the epidermis. Keratinocytes surrounding a wound increased expression of the genes coding for the microbial pattern recognition receptors CD14 and TLR2, complementing an increase in cathelicidin antimicrobial peptide expression. These genes were induced by 1,25(OH)2 vitamin D3 (1,25D3; its active form), suggesting a role for vitamin D3 in this process. How 1,25D3 could participate in the injury response was explained by findings that the levels of CYP27B1, which converts 25OH vitamin D3 (25D3) to active 1,25D3, were increased in wounds and induced in keratinocytes in response to TGF-beta1. Blocking the vitamin D receptor, inhibiting CYP27B1, or limiting 25D3 availability prevented TGF-beta1 from inducing cathelicidin, CD14, or TLR2 in human keratinocytes, while CYP27B1-deficient mice failed to increase CD14 expression following wounding. The functional consequence of these observations was confirmed by demonstrating that 1,25D3 enabled keratinocytes to recognize microbial components through TLR2 and respond by cathelicidin production. Thus, we demonstrate what we believe to be a previously unexpected role for vitamin D3 in innate immunity, enabling keratinocytes to recognize and respond to microbes and to protect wounds against infection.

[1]  R. Gallo,et al.  Control of the innate epithelial antimicrobial response is cell‐type specific and dependent on relevant microenvironmental stimuli , 2006, Immunology.

[2]  T. Hökfelt,et al.  The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection , 2006, Nature Medicine.

[3]  R. Bouillon,et al.  UVB‐induced production of 1,25‐dihydroxyvitamin D3 and vitamin D activity in human keratinocytes pretreated with a sterol Δ7‐reductase inhibitor , 2006, Journal of cellular biochemistry.

[4]  M. Zasloff Fighting infections with vitamin D , 2006, Nature Medicine.

[5]  Maureen L. Coleman,et al.  Genomic Islands and the Ecology and Evolution of Prochlorococcus , 2006, Science.

[6]  S. Akira,et al.  Pathogen Recognition and Innate Immunity , 2006, Cell.

[7]  D. Tamandl,et al.  Vitamin D3 down‐regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen‐associated molecular patterns , 2006, European journal of immunology.

[8]  F. Granath,et al.  UVB upregulates the antimicrobial protein hCAP18 mRNA in human skin. , 2005, The Journal of investigative dermatology.

[9]  V. Nizet,et al.  Keratinocyte Production of Cathelicidin Provides Direct Activity against Bacterial Skin Pathogens , 2005, Infection and Immunity.

[10]  C. Mathieu,et al.  Immune Regulation of 25‐Hydroxyvitamin‐D3‐1α‐Hydroxylase in Human Monocytes , 2005 .

[11]  F. Fahrenholz,et al.  Genomic structure and functional characterization of the human ADAM10 promoter , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  R. Gallo,et al.  Anti-fungal activity of cathelicidins and their potential role in Candida albicans skin infection. , 2005, The Journal of investigative dermatology.

[13]  V. Nizet,et al.  Cutaneous defense mechanisms by antimicrobial peptides. , 2005, The Journal of investigative dermatology.

[14]  H. Koeffler,et al.  Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up‐regulated in myeloid cells by 1,25‐dihydroxyvitamin D3 , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  Zhengfan Jiang,et al.  CD14 is required for MyD88-independent LPS signaling , 2005, Nature Immunology.

[16]  H. Törmä,et al.  Vitamin D induces the antimicrobial protein hCAP18 in human skin. , 2005, The Journal of investigative dermatology.

[17]  Thomas Hartung,et al.  CD36 is a sensor of diacylglycerides , 2005, Nature.

[18]  Glenville Jones,et al.  Enzymes involved in the activation and inactivation of vitamin D. , 2004, Trends in biochemical sciences.

[19]  Richard Rodríguez,et al.  Association between vitamin D receptor gene polymorphisms and response to treatment of pulmonary tuberculosis. , 2004, The Journal of infectious diseases.

[20]  John H. White,et al.  Cutting Edge: 1,25-Dihydroxyvitamin D3 Is a Direct Inducer of Antimicrobial Peptide Gene Expression1 , 2004, The Journal of Immunology.

[21]  C. Mathieu,et al.  Regulation of 25-hydroxyvitamin d-1α-hydroxylase by IFNγ in human monocytic THP1 cells , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[22]  P. Elias,et al.  Mice lacking 25OHD 1α-hydroxylase demonstrate decreased epidermal differentiation and barrier function , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[23]  C. Mathieu,et al.  Regulation of 25-hydroxyvitamin d-1alpha-hydroxylase by IFNgamma in human monocytic THP1 cells. , 2004, The Journal of steroid biochemistry and molecular biology.

[24]  D. Bikle,et al.  Calcium and 1,25(OH)2D: interacting drivers of epidermal differentiation , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[25]  S. Filteau,et al.  Association of subclinical vitamin D deficiency with severe acute lower respiratory infection in Indian children under 5 y , 2004, European Journal of Clinical Nutrition.

[26]  Göran Carlsson,et al.  Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study , 2002, The Lancet.

[27]  R. Gallo,et al.  Cathelicidins, essential gene-encoded mammalian antibiotics , 2002, Journal of Molecular Medicine.

[28]  Takaaki Ohtake,et al.  Innate antimicrobial peptide protects the skin from invasive bacterial infection , 2001, Nature.

[29]  M. Meurer,et al.  UVB-Induced Conversion of 7-Dehydrocholesterol to 1α,25-Dihydroxyvitamin D3 in an In Vitro Human Skin Equivalent Model , 2001 .

[30]  V. Nizet,et al.  Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. , 2001, The Journal of investigative dermatology.

[31]  A. Dusso,et al.  ␥-interferon-induced Resistance to 1,25-(oh) 2 D 3 in Human Monocytes and Macrophages: a Mechanism for the Hypercalcemia of Various Granulomatoses* , 2022 .

[32]  H. Vindenes,et al.  Microbial colonization of large wounds. , 1995, Burns : journal of the International Society for Burn Injuries.

[33]  M. Holick,et al.  1,25‐Dihydroxyvitamin D3: A novel agent for enhancing wound healing , 1995, Journal of cellular biochemistry.

[34]  D. Tenen,et al.  Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3. , 1994, Journal of immunology.

[35]  S. Yamamoto,et al.  Identification of a tissue-specific regulatory element within the murine CD14 gene. , 1992, The Journal of biological chemistry.

[36]  D. Bikle,et al.  Tumor Necrosis Factor-α Regulation of 1,25-Dihydroxy vitamin D Production by Human Keratinocytes* , 1991 .

[37]  J. Adams,et al.  Transpleural gradient of 1,25-dihydroxyvitamin D in tuberculous pleuritis. , 1989, The Journal of clinical investigation.

[38]  D. Bikle,et al.  Regulation of 1,25-dihydroxyvitamin D production in human keratinocytes by interferon-gamma. , 1989, Endocrinology.

[39]  H. Koeffler,et al.  gamma-Interferon stimulates production of 1,25-dihydroxyvitamin D3 by normal human macrophages. , 1985, Biochemical and biophysical research communications.